Optimal duration of dual antiplatelet therapy after percutaneous ...
Background: Dual antiplatelet therapy (DAPT) is the primary medication for patients after percutaneous coronary intervention (PCI). However, the ...
Comparison of short-term DAPT and long-term ... - Research SquareBACKGROUND: The appropriate duration of dual antiplatelet therapy (DAPT) and risk-benefit ratio for long-term DAPT in patients with left main (LM) disease ... Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug ...x The MASTER DAPT trial investigated an abbreviated (1 month) versus nonabbreviated. (3í12 month) dual antiplatelet therapy (DAPT) and a ... P2Y12 Receptor Inhibitors After Percutaneous Coronary Syndromespost-PCI treatment, especially Dual Antiplatelet Therapy (DAPT), still caused many patients to prematurely discontinue ... with intermediate-term DAPT (6?12 ...
Autres Cours:
